Byram Bridle

Byram Bridle  (immunologist, academic)
Nationality	Canadian
Alma mater	University of Guelph, McMaster University
Interests	• Pfizer–BioNTech COVID-19 vaccine • COVID-19
Canadian immunologist who found himself under attack from his own government after he in early 2021 went public with grave warnings about the Pfizer–BioNTech COVID-19 vaccine

“We made a big mistake. We didn’t realize it until now... We thought the spike protein was a great target antigen... So by vaccinating people we are inadvertently inoculating them with a toxin.... We have known for a long time that the spike protein is a pathogenic protein. It is a toxin. It can cause damage in our body if it gets into circulation... Now, we have clear-cut evidence that the vaccines that make the cells in our deltoid muscles manufacture this protein — that the vaccine itself, plus the protein — gets into blood circulation.”
Professor Byram Bridle (February 24, 2021) 

Byram Bridle is a viral immunologist and professor at the University of Guelph in Canada, where he leads his own research team. With a Canadian government grant, he and his lab in 2020 started researching on COVID vaccine development. He is a member of the Scientific and Medical Advisory Committee of the Canadian Covid Care Alliance (CCCA).

After going public in early 2021 with grave warnings about what the Pfizer–BioNTech COVID-19 vaccine and others were supposed to do versus what they’re actually doing, he found himself under attack from the Canadian government, who even paid front organizations to create websites with his name in it (ByramBridle.com), calling him a quack.

Career

After going public in early 2021 with grave warnings about what the Pfizer–BioNTech COVID-19 vaccine and others were supposed to do versus what they’re actually doing, he found himself under attack from the Canadian government, who even paid front organizations to create websites with his name in it (ByramBridle.com), calling him a quack

Dr. Bridle received graduate training in immunology at the University of Guelph and then postdoctoral training as a viral immunologist at McMaster University.

The research program in the Bridle lab has two focus areas. One is to develop novel, highly targeted biotherapies for the treatment of cancers. A second emphasis of the lab is the study of host responses to viruses. An area of focus is developing a better understanding of the mechanisms underlying virus-induced cytokine storms.

Funding

The Bridle lab has been sponsored by the Canadian Institutes of Health Research, National Centre of Excellence in Biotherapeutics for Cancer Treatment, Canadian Foundation for Innovation - (BioCanRx), Ontario COVID-19 Rapid Research Fund, Ministry of Research and Innovation Ontario Research Fund and several other government bodies.

COVID vaccine warnings

“But this is because these COVID-19 vaccines have reached the public rollout phase by, and I’ll say it in quotes, “cutting corners”. And by cutting corners, I’m not implying that people were skipping key steps, although honestly, there could be some potential questions around that.”
Professor Byram Bridle (February 24, 2021) 

“None of us were expecting, I don’t think, that the vaccines would be rolled out very early on in the phase three clinical trials. So the phase three trials are not done. So in essence, what this means is the public rollout right now is an extension of the phase three clinical trial. So those being vaccinated now are, whether they realize it or not, part of the phase three experiment.”
Professor Byram Bridle (February 24, 2021) 

 

A Quote by Byram Bridle

Page	Quote	Date
COVID-19/Vaccine/Safety	“knowing the virus, knowing these vaccines, knowing these two areas of science, I am quite confident that it’s just a matter of time before we will have a number of variants that can readily bypass this narrowly focused immunity that these vaccines confer.”	12 February 2021

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.